A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer
Crossref DOI link: https://doi.org/10.1007/s10120-014-0423-6
Published Online: 2014-09-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bokemeyer, Carsten
Stein, Alexander
Ridwelski, Karsten
Atanackovic, Djordje
Arnold, Dirk
Wöll, Ewald
Ulrich, Alexis
Fischer, Ramona
Krüger, Colin
Schuhmacher, Christoph
Text and Data Mining valid from 2014-09-12